Fumonisins are sphinganine analogues produced by Fusarium moniliforme
and related fungi. They inhibit ceramide synthase and block the biosyn
thesis of complex sphingolipids, promoting accumulation of sphinganine
and sphinganine I-phosphate. Disruption of sphingolipid metabolism by
fumonisin B-1 alters cell-cell interactions, the behaviour of cell-su
rface proteins, the activity of protein kinases, the metabolism of oth
er lipids, and cell growth and viability. This multitude of effects pr
obably accounts for the toxicity and carcinogenicity of these mycotoxi
ns. Naturally occurring inhibitors of sphingolipid metabolism such as
fumonisins are proving to be powerful tools for studying the diverse r
oles of sphingolipids in cell regulation and disease.